Short answer
CONMED Corp (CNMD) filed its Q3 2025 10-Q quarterly report on Nov 6, 2025 for the quarter ended Sep 30, 2025. Quarterly revenue was $338M (up 6.7% year over year) with net income of $3M.
Q3 2025 key financials · XBRL
- Revenue
- $338M
- +6.7% YoY · −1.3% QoQ
- Net income
- $3M
- −94.2% YoY · −86.7% QoQ
- Operating margin
- 3.5%
- Gross margin
- 49.2%
- EPS (diluted)
- $0.09
- −94.3% YoY · −87.0% QoQ
Source: XBRL data from the CONMED Corp (CNMD) Q3 2025 10-Q on SEC EDGAR. USD.
CONMED Corp Q3 2025 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Q3 revenue $337.9M, up 6.7% YoY from $316.7M
- Gross margin 49.2% vs 56.5%; operating margin 3.5% vs 20.7% YoY
- Best segment General Surgery $199.7M, up 7.3%; Orthopedic Surgery $138.2M, up 5.9%
- Nine-month operating cash flow $124.4M vs $123.6M; capital expenditures $14.7M vs $9.0M
- Inflation, supply-chain challenges, tariffs and higher costs; management may reduce costs or refinance debt
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other CONMED Corp quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.